Literature DB >> 2658019

Host response in women with symptomatic urinary tract infection.

T Sandberg1, G Lidin-Janson, C S Edén.   

Abstract

The agreement between clinical signs and host response was analysed in 174 women with symptomatic urinary tract infection. C-reactive protein (CRP) confirmed the clinical diagnosis in that 94% of non-pregnant and 91% of pregnant women with acute pyelonephritis had serum levels greater than or equal to 30 mg/l, compared with only 5% of cystitis patients. There was a significant increase in the erythrocyte sedimentation rate (ESR) and reduction of the renal concentrating capacity in patients with acute pyelonephritis, although the overlap with the cystitis group was greater than for CRP. The transient decrease in urine osmolality was unrelated to age, as were CRP, ESR and the total white blood cell count. Pregnant women had higher ESR but lower CRP levels than non-pregnant women with acute pyelonephritis. The renal concentrating capacity was more reduced in those infected with Escherichia coli expressing adhesins specifically recognizing Gal alpha 1----4Gal beta-containing receptors on uroepithelial cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2658019     DOI: 10.3109/00365548909035682

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  Association of spontaneous expulsion with C-reactive protein and other clinico-demographic factors in patients with lower ureteric stone.

Authors:  Amit Jain; Sreerag Kodakkattil Sreenivasan; Ramanitharan Manikandan; Lalgudi Narayanan Dorairajan; Sujatha Sistla; Subathra Adithan
Journal:  Urolithiasis       Date:  2019-04-25       Impact factor: 3.436

2.  Pregnancies in women with and without renal scarring after urinary infections in childhood.

Authors:  J Martinell; U Jodal; G Lidin-Janson
Journal:  BMJ       Date:  1990-03-31

3.  Stone expulsion rate of small distal ureteric calculi could be predicted with plasma C-reactive protein.

Authors:  Hussein A Aldaqadossi
Journal:  Urolithiasis       Date:  2013-03-07       Impact factor: 3.436

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.